Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 860 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Oragenics LPT3-04 found to reduce body weight

LPT3-04 is a natural occurring dietary substance with proven safety and tolerance profile. The double-blind placebo-controlled human clinical study randomized 32 healthy, overweight and mildly obese adult volunteers

Valeant to purchase Eyetech

The acquisition is subject to an upfront payment and potential future milestones that total significantly less than two times sales, the company said. The transaction is expected to

Nouveau Life to develop natural product for FSD

The company is currently focused on developing proprietary blends of all natural ingredients to provide females with a solution for female sexual dysfunction (FSD). Hybrid Fuels CEO Ramiro

AiCuris Letermovir trial meets primary efficacy endpoints

In the placebo-controlled study, Letermovir demonstrated efficacy, superior tolerability and safety. 133 HCMV-seropositive allogeneic human blood precursor cell (HBPC) recipients were included in the trial. The efficacy endpoints